These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7099478)

  • 1. [Breast development with drug therapy in male pseudohermaphroditism].
    Zara C; Nava C; Montanari L; Polatti F
    Minerva Ginecol; 1982 Apr; 34(4):265-9. PubMed ID: 7099478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Measure of the transcortin-binding capacity in the syndrome of male pseudohermaphroditism with testicular feminization].
    Tremblay RR; Ho-Kim MA; Migeon CJ
    Union Med Can; 1975 Mar; 104(3):411-3. PubMed ID: 1162771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertrichosis and hirsutism: current diagnostic and therapeutic directions. Our experience in 55 cases].
    Carrano M; Mancuso M; Trotta V
    Minerva Ginecol; 1984 Sep; 36(9):493-7. PubMed ID: 6514219
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of female hyperandrogenism: estroprogestinic therapy at low dose in an inversal sequential scheme.
    Ragonesi FP; Lo Mastro F; Arena V; Ermini M
    Acta Eur Fertil; 1995; 26(4):141-3. PubMed ID: 9098476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
    Luboshitzky R; Herer P; Shen-Orr Z
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
    Lemay A; Dodin S; Turcot L; Déchêne F; Forest JC
    Hum Reprod; 2006 Jan; 21(1):121-8. PubMed ID: 16199428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
    Luboshitzky R; Herer P; Shen-Orr Z
    Neuro Endocrinol Lett; 2002 Aug; 23(4):309-13. PubMed ID: 12195232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
    Gul OB; Somunkiran A; Yucel O; Demirci F; Ozdemir I
    Arch Gynecol Obstet; 2008 Jan; 277(1):25-30. PubMed ID: 17618446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer.
    Beex L; Pieters G; Smals A; Koenders A; Benraad T; Kloppenborg P
    Cancer Treat Rep; 1981; 65(3-4):179-85. PubMed ID: 7237448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast fibroadenoma in a male-to-female transsexual patient after hormonal treatment.
    Lemmo G; Garcea N; Corsello S; Tarquini E; Palladino T; Ardito G; Garcea R
    Eur J Surg Suppl; 2003 Jul; (588):69-71. PubMed ID: 15200048
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
    Luque-Ramírez M; Alvarez-Blasco F; Uriol Rivera MG; Escobar-Morreale HF
    Hum Reprod; 2008 Jul; 23(7):1594-601. PubMed ID: 18375410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
    Marianowski L; Cyganek A; Grzechocińska B
    Wiad Lek; 1994 Oct; 47(19-20):745-6. PubMed ID: 7483620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2005 Dec; (14):2343-51. PubMed ID: 16620491
    [No Abstract]   [Full Text] [Related]  

  • 15. [Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
    Brzezińska-Wcisło L
    Wiad Lek; 2003; 56(3-4):202-5. PubMed ID: 12923971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
    Redmond GP; Olson WH; Lippman JS; Kafrissen ME; Jones TM; Jorizzo JL
    Obstet Gynecol; 1997 Apr; 89(4):615-22. PubMed ID: 9083323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethinyl estradiol and medroxyprogesterone treatment in advanced breast cancer: a pilot study.
    Pellegrini A; Massidda B; Mascia V; Ionta MT; Lippi MG; Muggiano A; Carboni E; Robustelli della Cuna G; Bernardo G; Strada MR; Pavesi L
    Cancer Treat Rep; 1981; 65(1-2):135-6. PubMed ID: 7226163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2004 Dec; (12):2678-88. PubMed ID: 15865813
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of gigantic girls and boys].
    Hinkel GK
    Kinderarztl Prax; 1980 Feb; 48(2):89-97. PubMed ID: 7366082
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
    Vaidya RA; Shringi MS; Vaidya AB; Gogate JG
    J Assoc Physicians India; 1997 Nov; 45(11):883-4. PubMed ID: 11229194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.